DaVita (DVA)
(Real Time Quote from BATS)
$129.56 USD
-0.55 (-0.42%)
Updated Sep 17, 2025 10:52 AM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DVA 129.56 -0.55(-0.42%)
Will DVA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DVA
Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
DVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
DaVita HealthCare (DVA) Stock Drops Despite Market Gains: Important Facts to Note
Should Value Investors Buy DaVita (DVA) Stock?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Other News for DVA
Is DVA about to break its pattern? NR7 shows up after declining 0.64%
Most shorted S&P500 stocks in August
DVA's price falls by 1.67% on September 15, though its technical setup remains stable.
Noteworthy Monday Option Activity: DVA, STZ, DAL
Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock